Top

Breast Cancer Research

Published in:

01-05-2008 | Poster presentation

Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers

Published in: Breast Cancer Research | Special Issue 2/2008

Title: Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers
Publication date: 01-05-2008
Published in: Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr1970

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Special Issue 2/2008

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid

Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer

Identification and role of migration stimulating factor isoforms in breast carcinomas

'The sooner the better' or 'too much too soon'? A pilot prospective longitudinal study to evaluate quality of life and body image following immediate latissimus dorsi breast reconstruction

Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach

Regulation of cyclin D1by the BRCA1–BARD1 complex

Keynote webinar | Spotlight on antibody–drug conjugates in cancer